These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 23410063

  • 1. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
    Xu Y, Gao C, Li X, He Y, Zhou L, Pang G, Sun S.
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
    [Abstract] [Full Text] [Related]

  • 2. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y, Pang GR, Zhao DQ, Gao CW, Zhou LT, Sun ST, Wang BL, Chen ZJ.
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS, Mythili A, Homa M, Galgóczy L, Priya R, Babu Singh YR, Panneerselvam K, Vágvölgyi C, Kredics L, Narendran V, Manikandan P.
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
    Todokoro D, Suzuki T, Tamura T, Makimura K, Yamaguchi H, Inagaki K, Akiyama H.
    Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
    Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Cevallos V, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Am J Ophthalmol; 2014 Feb; 157(2):318-26. PubMed ID: 24439440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Natamycin and Azithromycin Are Synergistic In Vitro against Ocular Pathogenic Aspergillus flavus Species Complex and Fusarium solani Species Complex Isolates.
    Guo H, Zhou L, He Y, Gao C, Han L, Xu Y.
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735563
    [Abstract] [Full Text] [Related]

  • 11. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
    Wang L, Wang L, Han L, Yin W.
    Curr Eye Res; 2015 Jul; 40(11):1095-101. PubMed ID: 26268399
    [Abstract] [Full Text] [Related]

  • 12. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y, Pang GR, Lü XF, Chen ZJ, Sun ST, Song JZ.
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [Abstract] [Full Text] [Related]

  • 13. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ, Boey A, Park BJ, Brandt ME.
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [Abstract] [Full Text] [Related]

  • 14. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY, Yao YF, Zhu YF, Zhang YM, Zhou P, Jin YQ, Zhang B.
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [Abstract] [Full Text] [Related]

  • 15. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
    Sun S, Lyu Q, Han L, Ma Q, Hu H, He S, Tao S, Zhang J, Zhang H, Wang L.
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM.
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [Abstract] [Full Text] [Related]

  • 17. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi.
    Xu Y, Pang G, Gao C, Zhao D, Zhou L, Sun S, Wang B.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1636-8. PubMed ID: 19139289
    [Abstract] [Full Text] [Related]

  • 18. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
    Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X.
    Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M, Naik R, Sidhu N, Ahmed NH, Gupta N, Tandon R.
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW, Giuliano EA, Moore CP.
    Vet Ophthalmol; 2009 Dec; 12(5):318-24. PubMed ID: 19751493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.